Total Number of Excess Deaths >14.7 Million in U.S. in 1980 to 2023
By Elana Gotkine HealthDay Reporter
THURSDAY, May 29, 2025 -- There were 14,735,913 excess deaths in the United States during 1980 to 2023 compared with other high-income countries (HICs), according to a research letter published online May 23 in JAMA Health Forum.
Jacob Bor, S.D., from the Boston University School of Public Health, and colleagues assessed trends in excess U.S. deaths before (1980 to 2019), during (2020 to 2022), and after (2023) the acute phase of the COVID-19 pandemic using all-cause mortality data for the United States and 21 other HICs from the Human Mortality Database.
The analysis included 107,586,398 deaths in the United States and 230,208,265 deaths in other HICs from 1980 to 2023. Compared with other HICs, the researchers estimated that 14,735,913 excess deaths occurred in the United States in this period. During the pandemic, in 2020 and 2021, U.S. mortality rose rapidly, then declined in 2022 and 2023. In other HICs, the pandemic-era mortality surge was less pronounced. Before and during the pandemic, relative differences between the United States and other HICs widened, especially among younger adults, before contracting in 2022 and 2023. Comparing the United States with the average of other HICs, the age-standardized mortality rate ratios were 1.20, 1.28, 1.46, and 1.30 in 2010, 2019, 2021, and 2023, respectively. The rising trend in excess U.S. deaths before 2020 continued during the pandemic; excess deaths in 2023 were lower than in 2020 to 2022 but were higher than in 2019 and consistent with the slope established from 2014 to 2019.
“These deaths reflect not individual choices, but policy neglect and deep-rooted social and health system failures,” senior author Andrew Stokes, Ph.D., also from the Boston University School of Public Health, said in a press release. “The COVID-19 pandemic exposed structural weaknesses -- including gaps in health care access and social supports -- that have continued to fuel premature deaths even after the acute phase of the pandemic ended.”
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-30 06:00
Read more

- Sugar, Fat and Salt on the Rise in U.S. Breakfast Cereals, Study Shows
- Otsuka Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
- Odds of Burnout Higher for Doctors Working With Incompletely Staffed Team
- FDA Approves Yutrepia (treprostinil) Inhalation Powder for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
- Scientists Find Gene That Helps Explain Why Men Are Taller Than Women
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions